Bispecific targetting11 Jan 2022 10:17
Seems like this company is in an exciting area with the need to improve chemo targeting.Early days but some good mouse data and a IP plan in process ahead of trying to partner later in the year.Funded for 18 months or so and based in the happening Alderley Park.This can be £100-200m in the blink of an eye.I dont see the placing price being visited again